Skip to main content
. 2020 Feb 17;13(6):994–1002. doi: 10.1093/ckj/sfaa002

Table 3.

Progression of AKI during the first 48 h of ICU admission based on KDIGO criteria for SCr or urine output alone

AKI creatinine AKI urine output

Variable No progression (n = 337) Progression (n = 24) P-value No progression (n = 248) Progression (n = 32) P-value
Age (years), mean ± SD 60 ± 16 62 ± 13 0.59 60 ± 16 63 ± 15 0.35
Sex, n (%) 0.09 0.07
 Male 213 (63) 11 (46) 157 (63) 15 (47)
 Female 124 (37) 13 (54) 91 (37) 17 (53)
DM, n (%) 0.42 0.24
 No 275 (82) 18 (75) 195 (79) 28 (88)
 Yes 62 (18) 6 (25) 53 (21) 4 (13)
APACHE, mean ± SD 54 ± 28 85 ± 28 <0.001 53 ± 26 75 ± 29 <0.001
Weight (kg), mean ± SD 79.8 ± 16.4 78.1 ± 16.5 0.63 79.5 ± 16.3 76.6 ± 178 0.40
BMI (kg/m2), mean ± SD 26.3 ± 4.7 26.4 ± 4.6 0.88 26.1± 4.6 26 ± 5.6 0.87
Creatinine at admission (µmol/L), median (IQR) 71 (58–91) 114 (92–141) <0.001 70 (58–94) 76 (56–127) 0.4
NGAL at admission (µmol/L), median (IQR) 121 (82–194) 266 (157–458) <0.001 121 (85–214) 170 (130–371) 0.02
Confirmed infection at admission, n (%) 0.27 0.9
 No 315 (94) 21 (88) 231 (93) 30 (94)
 Yes 22 (7) 3 (13) 17 (7) 2 (6)
KDIGO stage admission, n (%) <0.001 0.05
 0 284 (84) 13 (54) 208 (84) 22 (69)
 1 20 (6) 9 (38) 17 (7) 6 (19)
 2 17 (5) 2 (8) 13 (5) 1 (3)
 3 16 (5) 0 (0) 10 (4) 3 (9)
RRT during admission, n (%) 11 (3.3) 8 (33) <0.001 11 (4) 5 (16) 0.01
Admission type, n (%) 0.03 0.01
 Scheduled surgery 175 (52) 6 (25) 129 (52) 7 (22)
 Unscheduled surgery 44 (13) 6 (25) 35 (14) 7 (22)
 Medical 118 (35) 12 (50) 84 (34) 18 (56)
ICU survival, n (%) 0.34 0.56
 No 35 (10) 4 (17) 23 (9) 4 (13)
 Yes 302 (90) 20 (83) 225 (91) 28 (88)
ICU LoS (calendar days), median (IQR) 2 (2–4) 7 (4–10) 0.05 2 (2–5) 7.5 (4–16) <0.001

LoS:length of stay.